The authors say increased attention to gut and adipose hormones will reveal pathways to treat infertility.
Rising global obesity rates have been public health officials’ radar for some time. In January, the World Health Organization (WHO) issued a report from a special commission that called for soda taxes, limits on marketing of unhealthy food, and other steps to stem the epidemic.
But besides diabetes and cardiovascular disease, there’s another silent health effect of obesity: male infertility, which authors of an editorial say doesn’t get enough attention.
Pedro F. Oliveira, PhD, and Marco G. Alves, PhD, both specialists in endocrinology and cell biology, write in a special issue of Current Pharmaceutical Design that recent attention to gut and adipose hormones will reveal more information about the links between obesity and infertility in males, as well as pathways for a therapeutic approach to treat this problem.
“Obesity is a metabolic disease that promotes strong hormonal dysfunction,” said Alves, who is first author on the paper. “Gut hormones are known to be strongly affected by energy unbalance induced by overconsumption of food. However, the impact of those hormones on the male reproductive system remains unknown.”
In their abstract, the authors write that overweight and obese men not only look different, but they have severe hormonal differences as well. Levels of ghrelin, leptin, and glucagon-like peptide-1 (GLP-1) are altered. Despite knowledge of the links between nutrition and reproductive health, distinct research into the effects of obesity on these hormones and resulting reproductive problems is lacking, the authors say. All 3 could be targets for anti-obesity drugs (GLP-1 is already a target for a class of anti-diabetic therapies.)
Thus, the authors suggest, targeting these hormones in anti-obesity therapy could also have positive reproductive health benefits for overweight men.
Olivera’s research team publishes frequently on this issue, and their work on Klinefelter syndrome, a genetic cause of infertility associated with metabolic disease, recently appeared in Molecular Reproduction and Development.
As the numbers of obese males increase, especially in developing countries, there is potential for related infertility to cause not only health but cultural challenges. The authors say policymakers and the media should pay more attention to findings in this area, as they highlight the global health problem.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More
2 Commerce Drive
Cranbury, NJ 08512